Agoracom Blog Home

Archive for the ‘Medical Marijuana Stocks’ Category

Namaste $N.ca $NXTTF announces achieving over 6,000 registered NamasteMD users ahead of July 1 target and launches new marketing initiatives $VAPE $VPCO $MCIG $ABCN.ca $ACG.ca $ACB $WEED.ca $HIP.ca

Posted by AGORACOM-JC at 8:43 AM on Monday, June 25th, 2018

Namaste large new

  • Company has exceeded its July 1st goal and has acquired over 6,000 registered users on NamasteMD with a 4.9-star rating based on 209 reviews on Apple iOS devices and a 4.7-star rating on Google Android based on 106 consumer reviews
  • Results have exceeded the Company’s July 1 target of 5,000 registered users and Namaste anticipates further acceleration of its database during the second half of the year with new marketing initiatives and strategic partnerships including applications of NamasteMD

VANCOUVER, June 25, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that the Company has exceeded its July 1st goal and has acquired over 6,000 registered users on NamasteMD with a 4.9-star rating based on 209 reviews on Apple iOS devices and a 4.7-star rating on Google Android based on 106 consumer reviews. These results have exceeded the Company’s July 1 target of 5,000 registered users and Namaste anticipates further acceleration of its database during the second half of the year with new marketing initiatives and strategic partnerships including applications of NamasteMD for Indigenous communities, targeted healthcare organizations, digital marketing and high-traffic content networks.

NamasteMD is Canada’s first fully-integrated medical cannabis telemedicine application available on iPhone and Android devices, which provides free consultations in an enhanced online environment. Namaste’s ability to acquire medical cannabis patients online, with an acquisition cost of only $59.00 per patient, will propel NamasteMD to become Canada’s largest database of Canadian medical cannabis patients.

Namaste is now focused on launching a comprehensive marketing strategy that will include content networks, digital marketing and PPC advertising. NamasteMD will provide remote access to rural communities which suffer from little access to healthcare services. The Company will leverage its technology in partnerships with rural Indigenous communities as well as specialized healthcare groups to further accelerate patient growth over the next six months.

Namaste is confident that it will achieve its goal of acquiring 50,000 patients in 2018, with a target of 200,000 in 2019. Namaste has firmly established itself as a global innovator of technology platforms, e-commerce, telemedicine and artificial intelligence, all of which provide significant value to Namaste’s growing revenue and in creating innovation within the cannabis industry.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “We’re very pleased to see significant growth and acceleration of our NamasteMD platform. Recent updates to the app have allowed us to launch these new initiatives that will have a major impact on future growth. We’re developing strategic partnerships with various groups including Indigenous communities who will partner with Namaste as we provide a fully-integrated platform for patient acquisition through NamasteMD with a diverse offering of cannabis products through Cannmart. We’re presently acquiring patients faster than any of our industry peers, and at a fraction of the cost. At Namaste, we are dedicated to providing the best user experience possible through innovative technology platforms like NamasteMD. We’re looking forward to announcing further milestones as hard work and innovation pave the way to Namaste’s future.”

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer pending receipt of a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com

NamasteMD.com

NamasteVapes.ca

Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

View original content with multimedia:http://www.prnewswire.com/news-releases/namaste-announces-achieving-over-6-000-registered-namastemd-users-ahead-of-july-1-target-and-launches-new-marketing-initiatives-300671442.html

SOURCE Namaste Technologies Inc.

$APPB Applied BioSciences Launches Patented New Product CanaGel(TM) $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM at 9:45 AM on Tuesday, June 19th, 2018

 

https://s3.amazonaws.com/s3.agoracom.com/public/companies/logos/564626/hub/APPB_logo.png

  • Entered into a marketing and distribution agreement with CanaGel™ to launch their first patent-protected product, Hemp Oil Gel Melts
  • Independent lab tests show that after 2.5 minutes of contact, 80% of Phytocannabinoids were absorbed in vitro, and after just 5 minutes, virtually 100% of the nutrient-rich Phytocannabinoids were absorbed in vitro.
  • All CanaGel™ products are non-GMO, vegan, paleo, gluten-free, and sugar-free

 

LOS ANGELES, CA / ACCESSWIRE / June 19, 2018 / Applied BioSciences Corp. (OTCQB: APPB) (the “Company”), a diversified cannabinoid therapeutics company focused on the medical, bioceutical and pet health industries, today announced that the Company has entered into a marketing and distribution agreement with CanaGel™ to launch their first patent-protected product, Hemp Oil Gel Melts.

The Company continues to increase sales of hemp-derived products through its wholly owned divisions, Remedi and TherPet, and is now pleased to report that it will be adding the patented CanaGel™ Hemp Oil Gel Melts to its comprehensive suite of product offerings.

“Since all CanaGel™ products are non-GMO, vegan, paleo, gluten-free, and sugar-free, we knew that consumers would be interested in an exciting new alternative to the existing oils, capsules, edibles and chewables on the market,” commented Chris Bridges, President of Applied BioSciences Corp.

Independent lab tests show that after 2.5 minutes of contact, 80% of Phytocannabinoids were absorbed in vitro, and after just 5 minutes, virtually 100% of the nutrient-rich Phytocannabinoids were absorbed in vitro.

Per the agreement, the Company will leverage its North American and European marketing and distribution channels to assist CanaGel™ in launching its first doctor-developed product.

“We are excited to be selected by CanaGel™ as its first marketing and distribution partner,” commented JJ Southard, Vice President of Products at Applied BioSciences. “By leveraging our strength in the hemp-derived products space, we expect to make waves with what lab tests show to be one of the highest bioavailable phytocannabinoid supplements on the market.”

About CanaGel™

Developed by an internationally renowned doctor and oral surgeon, CanaGel™ was designed to be simple, convenient and effective. CanaGel™is the first ever patented gel melts with Full-spectrum Phytocannabinoid Rich Hemp oil. The innovative, patented technology used in CanaGel™ is an easy way to get your daily hemp oil that is also Organic, Gluten and Sugar Free. Learn more at https://canagel.com/.

About Applied BioSciences Corp.

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

All of Applied BioSciences’ products are formulated with organic 99%+ pure cannabidiol along with our proprietary blend of certified organic botanicals, herbals and essential oils to further optimize bioavailability.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact

Email: [email protected] or [email protected]
To be added to the Applied BioSciences email distribution list, please email [email protected] with
APPB in the subject line.
Official Website: www.appliedbiocorp.com

Brands:

www.remedishop.com
www.therpet.com

Follow us:

Facebook @remedicbd & @therpetcbd
Instagram @remedishop & @therpet
Twitter @remedishop & @therpet

Marijuana Company of America $MCOA Launches New CBD-Infused Cosmetic Product hempSMART(TM) Face $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:34 AM on Tuesday, June 19th, 2018

15233 mcoa

  • Announced that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product, hempSMART™ Face
  • Each bottle of hempSMART™ Face is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (CBD) oil derived from the industrial hemp plant

Escondido, California–(June 19, 2018) – Marijuana Company of America, Inc. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the company’s hempSMART™ brand has launched its revolutionary new cosmetic product, hempSMART Face.

Each bottle of hempSMART Face is formulated with 150mg of full spectrum, non-psychoactive Cannabidiol (CBD) oil derived from the industrial hemp plant. The newly developed hempSMART topical is a nourishing facial moisturizer that combines CBD oil with a unique blend of ayurvedic herbs and botanicals that is designed to refresh, replenish, and restore your skin cells on your face.

The innovative new formula is rich in Omega 3, 6, 7 and 9, along with naturally occurring ceramides and contains synergistic ingredients such as Organic Aloe, Sabi Inchi Oil, Argan Kernel Oil, Macademia Seed Oil, Rose Hip Seed Oil, Pomegranate Seed Oil, Tulsi, Turmeric Oil, Frankinsense, Ashwaganda, Sweet Potato Root Extract, Coconut Oil, and Sea Buckthorn Oil.

MCOA’s CEO, Donald Steinberg, commented, “Our team is excited to announce the expansion of the hempSMART brand into the world of cosmetic products. HempSMART will continue to build upon our already established and unique formulations to provide our customers and affiliates with the tools needed to succeed in the wellness industry.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition as drugs or dietary supplements subject to the FDA’s jurisdiction.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

NNW Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Marijuana Company of America $MCOA Announces the Relaunch of Its Reformulated Patent Pending CBD Product hempSMART(TM) Brain $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:05 AM on Tuesday, June 5th, 2018

15233 mcoa

  • Company’s hempSMART™ brand has relaunched its flagship wellness product hempSMART™ Brain with 10mg of Cannabidiol (CBD) oil per serving
  • Developed to maintain mental clarity, alertness, focus and concentration as well as promote relaxation, restorative sleep, and support the repair and regeneration of brain cells, better known as neurogenesis

Escondido, California–(June 5, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that the Company’s hempSMART™ brand has relaunched its flagship wellness product hempSMART™ Brain with 10mg of Cannabidiol (CBD) oil per serving.

hempSMART Brain has been relaunched and redesigned with an improved formulation that includes 300mg per bottle of Full Spectrum, non-psychoactive, water soluble CBD oil per serving and contains a botanical blend of all-natural plant-based ingredients such as Ashwaganda, Fulvic Acid, Rhodiola Rosea Extract, Bacopa, L-Theanine, Green Tea Extract, and Huperzia Serrata.

hempSMART Brain has been developed to maintain mental clarity, alertness, focus and concentration as well as promote relaxation, restorative sleep, and support the repair and regeneration of brain cells, better known as neurogenesis. This unique formula promises to revolutionize the safe, effective, and natural optimization of brain wellness.

MCOA‘s CEO Donald Steinberg stated, “After reviewing our hempSMART Brain product, our formulators chose to improve upon the original product by doubling the original dosage of CBD. Our team is proud to be able to welcome our flagship product back onto the market and look forward to the upcoming marketing campaigns.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication, and disclaims CBD as a dietary supplement. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

NNW Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

Marijuana Company of America $MCOA and Global Hemp Group $GHG.ca Provide Update on New Brunswick Hemp Project $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:40 AM on Wednesday, May 30th, 2018

15233 mcoa

  • Planting of the seeds on the first 77 acres will be completed this week
  • Remaining 48 acres will be seeded over the next two weeks, once the farmers receive soil test results for this acreage and are able to determine fertilizer requirements for this year’s cultivation

Escondido, California–(May 30, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to provide an update on its 125-acre industrial hemp project in northeast New Brunswick with joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG).

The planting of the seeds on the first 77 acres will be completed this week. The remaining 48 acres will be seeded over the next two weeks, once the farmers receive soil test results for this acreage and are able to determine fertilizer requirements for this year’s cultivation.

The Department of Aquaculture Agriculture and Fisheries (DAAF) will also be conducting fertility trials on reserved plots at participating farms. DAAF will contribute the fertilizers to the project as part of these trials. The trials will be conducted at no cost to the project and are a clear indication of the collaborative relationship that has been established with DAAF.

In addition, there is an organic certification trial underway on an additional two-acre plot at the project. It will take three years to complete the organic certification process for this field. As part of the process, the plot will begin a three-year cultivation rotation of hemp, oats and a green manure crop to be defined at a later date. In three years this plot will produce certified organic CBD and organic oats, a crop with an excellent market.

Project managers are currently evaluating drying equipment that will be required to process the biomass after it is harvested. Drying will prepare the biomass for shipment to processors for extraction of the cannabinoids. Management is in discussions with a number of potential processing partners for this material. A final decision will be made in the coming weeks.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG), is headquartered in Vancouver, British Columbia, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

#Cannabis and #CBD Markets are Set to Increase in Value $N.ca $NXTTF $TBP.ca $MCOA

Posted by AGORACOM-JC at 3:59 PM on Tuesday, May 29th, 2018
  • U.S. medical cannabis market is projected to reach $19.48 billion by 2024
  • Projected growth is driven by the increasing acceptance of medical advantages associated with cannabis, particularly for patients dealing with cancer, diabetes and chronic pain

NEW YORK, May 29, 2018 — According to a report by Hexa Research, the U.S. medical cannabis market is projected to reach $19.48 billion by 2024. The projected growth is driven by the increasing acceptance of medical advantages associated with cannabis, particularly for patients dealing with cancer, diabetes and chronic pain. Symptoms and conditions that may be treated with cannabis products include cancer, HIV, AIDS, Alzheimer’s disease, and multiple sclerosis. Chronic pain accounted for 46 percent of the U.S. cannabis medical market share in 2016. According to the research, the solid cannabis edibles segment in 2016, within the U.S. market generated $2.47 billion in revenue and is expected to continue to dominate the cannabis industry to 2024. Chineseinvestors.com, Inc. (OTC: CIIX), Kush Bottles, Inc. (OTC: KSHB), General Cannabis Corporation (OTC: CANN), Isodiol International Inc. (OTC: ISOLF), PotNetwork Holdings, Inc. (OTC: POTN)

A major portion of the legal cannabis industry Cannabidiol products. Cannabidiol, or CBD, is one of at least 113 active cannabinoids identified in cannabis. The CBD market is growing rapidly in recent years due to CBD’s medical benefits. Sean Murphy, the Founder and Publisher of Hemp Business Journal, said: “Hemp Business Journal estimates the total retail value of all hemp products sold in the U.S. to be at least $688 million for 2016. We estimate the hemp industry will grow to $1.8 billion in sales by 2020, led by hemp food, body care, and CBD-based products. The data demonstrates the hemp industry is growing quickly at 22% five year CAGR and being led by food and body care products, with Hemp CBD products showing a 53% AGR.”

Source: https://www.prnewswire.com/news-releases/cannabis-and-cbd-markets-are-set-to-increase-in-value-683935941.html

FEATURE: Applied Biosciences – Poised to Succeed in CBD Market $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM at 7:18 AM on Tuesday, May 29th, 2018

        

  • Consumer company with Multiple CBD Brands focused on Consumer, Pet, Female and Health and Wellness
  • Building brand with a scalable process and operation
  • Commenced sales of its hemp-derived CBD products on LeafLink’s industry-leading B2B e-commerce platform
  • Launched CBD product line under the Remedi CBD brand
  • Products will be sold on Remedi’s new website (www.remedishop.com) and in select locations in the U.S.
  • Launched CBD product line under TherPet brand (https://therpet.com/)
  • Currently shipping to the majority of US states and Internationally to 5 countries
  • Several strategic partnerships and investments currently in place
  • Partners include: High Times & GemmaCert

Key Market Drivers

     Increasing Momentum Towards Legalization

  • Especially related to medical -use Cannabis
  • Cannabis is legal in 29 states and the District of Columbia in some form ( or decriminalized )
  • International Opportunities: * Cannabis is now trading globally, with Canadian      grown Medical cannabis being exported to Germany, Croatia, New Zealand, Brazil and Chile. The Dutch are sending shipments of medical cannabis to Italy, Germany and Finland.   

     Shifting Public Opinion

  • Belief that the growth of the regulated cannabis industry has been fueled by changing public attitudes in the United States. A 2015 poll by Harris found 81% of Americans support the legalization of cannabis for medical use. Driven in part by this shift in public opinion.       

                        

 

 

About Applied BioSciences Corp.

Applied BioSciences Corp. (www.appliedbiocorp.com), is a diversified company focused on multiple areas of the medical, bioceutical and pet health industry. As a leading company in the CBD and Pet health space, the company is currently shipping to the majority of US states as well as to 5 International countries. The company is focused on select investment, consumer brands, and partnership opportunities in the recreational, health and wellness, nutraceutical, and media industries.

The company has several strategic partnerships and investments currently in place and is actively pursuing additional partnerships and strategic growth opportunities.

Contact

Email: [email protected] or [email protected]

To be added to the Applied BioSciences email distribution list, please email [email protected] with APPB in the subject line.

Official Website: www.appliedbiocorp.com

Brands:

www.remedishop.com
www.therpet.com

Follow us:

Facebook @remedicbd & @therpetcbd
Instagram @remedicbd & @therpet
Twitter @remedishop & @therpet

Namaste $N.ca Announces Definitive Agreement to Commercialize Needle-Free Injector Technology for Medical #Cannabis With Inolife R&D Inc. and Participates as Lead Order in Financing Round $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:06 AM on Wednesday, May 23rd, 2018
  • Company has signed a definitive agreement with Inolife R&D Inc.
  • whereby Namaste is granted exclusive rights to the commercialization of Inolife’s innovative needle-free technology for applications of medical cannabis
  • Namaste intends to produce medical cannabis oil through its partnership with Infinite Labz Inc.

VANCOUVER, May 23, 2018  – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that further to the Letter of Intent (“LOI”) dated March 28th, 2018, the Company has signed a definitive agreement (the “Agreement”) with Inolife R&D Inc. (“Inolife”), whereby Namaste is granted exclusive rights to the commercialization of Inolife’s innovative needle-free technology for applications of medical cannabis, in accordance with Health Canada regulations.

Namaste intends to produce medical cannabis oil through its partnership with Infinite Labz Inc. (“Infinite Labz”) and to specifically formulate oil for use with Inolife’s injector technology. The Company believes that needle-free injection of cannabis oils could prove to be one of the most effective means of dosing through a painless device, with a fast absorption rate. Namaste will work with Inolife’s management team to develop standardized production procedures for oil production, and for testing or studies required to commercialize the technology for applications of medical cannabis in accordance with federal regulations.

Namaste is also pleased to announce that the Company is participating as the lead order in a non-brokered private placement offering (“Private Placement”), whereby Namaste will purchase 2,000,000 units of Inolife, issued at a price of $0.10 per unit. Each unit consists of one common share and one-half of one common share purchase warrant, with an exercise price of $0.20 per full warrant for a period of 24 months from the Private Placement closing date. Inolife has also chosen to appoint Namaste’s CEO Sean Dollinger to Inolife’s executive board of directors. Namaste’s management team believes that Inolife’s needle-free technology can offer significant long-term value for the medical cannabis market.

Key Terms of the Agreement

  • Namaste shall have and retain exclusive rights to the procurement and/or production of the oil required to meet the requirements and standards set out and outlined in the testing, studies, and evaluations of the products in accordance with Health Canada and/or any other regulatory agency requirements.
  • During the term of the Agreement, further testing, studies, and evaluations may be required by a regulatory agency or third party that may be interested in utilizing the needle-free injectors for the commercial use in the medical cannabis industry.
  • During the term of the Agreement, Namaste and Inolife must agree on who will conduct the testing, studies, and evaluations of the needle-free injectors.
  • The purpose of testing, studies, and evaluations of the needle-free injectors shall be primarily to determine the method on how to best produce medical cannabis oil that would be suitable for needle-free injection.
  • The Agreement shall extend to any future technology and implementations of the Inolife products, such as needle-free injectors using Inolife’s powder-based system.

Management Commentary

Michael Wright, President and CEO of Inolife comments, “The relationship between Inolife and Namaste heralds a new era for the medical cannabis industry. We’re pleased to see the opportunities for our innovative needle-free device technology to be used to deliver cutting-edge treatment from medical cannabis. Our commitment to improving quality of life for patients remains at the forefront of all our endeavors and we feel that Namaste will be an excellent partner.”

Sean Dollinger, President, and CEO of Namaste comments; “We are very excited to have signed the definitive agreement with Inolife. We are focused on partnerships with companies with innovative technology, and Inoflie’s technology could revolutionize the way medical patients with severe conditions are able to meter accurate doses of cannabis in a safe, effective and pain-free way. We anticipate that upon commercialization, Namaste will be able to leverage its relationships to produce pre-filled injectors with medical cannabis. I’m very pleased to be joining Inolife’s board of directors and hope to offer value to their team. We feel strongly that our investment and partnership with Inolife will create strong, long-term value for both companies and their shareholders.”

About Inolife R&D Inc.

Inolife R&D Inc. is an emerging, specialty medical device company focused on developing and commercializing self-administered medical products using novel drug delivery technologies. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection. We believe this technology will improve a patient’s quality of life by making medicines more effective and easier to self-administer, and that it will also eliminate the anxiety and inconvenience associated with hypodermic needle injections.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/23/c2011.html

Sean Dollinger, Chief Executive Officer, Direct: +1 (786) 389 9771, Email: [email protected]; Vancouver, BC, V6C 2B5, Main : + 1 (786) 389-9771, namastetechnologies.com, [email protected] CNW Group 2018

 

VANCOUVER, May 23, 2018  – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N)(FRA: M5BQ)(OTCMKTS: NXTTF) is pleased to announce that further to the Letter of Intent (“LOI”) dated March 28th, 2018, the Company has signed a definitive agreement (the “Agreement”) with Inolife R&D Inc. (“Inolife”), whereby Namaste is granted exclusive rights to the commercialization of Inolife’s innovative needle-free technology for applications of medical cannabis, in accordance with Health Canada regulations.

Namaste intends to produce medical cannabis oil through its partnership with Infinite Labz Inc. (“Infinite Labz”) and to specifically formulate oil for use with Inolife’s injector technology. The Company believes that needle-free injection of cannabis oils could prove to be one of the most effective means of dosing through a painless device, with a fast absorption rate. Namaste will work with Inolife’s management team to develop standardized production procedures for oil production, and for testing or studies required to commercialize the technology for applications of medical cannabis in accordance with federal regulations.

Namaste is also pleased to announce that the Company is participating as the lead order in a non-brokered private placement offering (“Private Placement”), whereby Namaste will purchase 2,000,000 units of Inolife, issued at a price of $0.10 per unit. Each unit consists of one common share and one-half of one common share purchase warrant, with an exercise price of $0.20 per full warrant for a period of 24 months from the Private Placement closing date. Inolife has also chosen to appoint Namaste’s CEO Sean Dollinger to Inolife’s executive board of directors. Namaste’s management team believes that Inolife’s needle-free technology can offer significant long-term value for the medical cannabis market.

Key Terms of the Agreement

  • Namaste shall have and retain exclusive rights to the procurement and/or production of the oil required to meet the requirements and standards set out and outlined in the testing, studies, and evaluations of the products in accordance with Health Canada and/or any other regulatory agency requirements.
  • During the term of the Agreement, further testing, studies, and evaluations may be required by a regulatory agency or third party that may be interested in utilizing the needle-free injectors for the commercial use in the medical cannabis industry.
  • During the term of the Agreement, Namaste and Inolife must agree on who will conduct the testing, studies, and evaluations of the needle-free injectors.
  • The purpose of testing, studies, and evaluations of the needle-free injectors shall be primarily to determine the method on how to best produce medical cannabis oil that would be suitable for needle-free injection.
  • The Agreement shall extend to any future technology and implementations of the Inolife products, such as needle-free injectors using Inolife’s powder-based system.

Management Commentary

Michael Wright, President and CEO of Inolife comments, “The relationship between Inolife and Namaste heralds a new era for the medical cannabis industry. We’re pleased to see the opportunities for our innovative needle-free device technology to be used to deliver cutting-edge treatment from medical cannabis. Our commitment to improving quality of life for patients remains at the forefront of all our endeavors and we feel that Namaste will be an excellent partner.”

Sean Dollinger, President, and CEO of Namaste comments; “We are very excited to have signed the definitive agreement with Inolife. We are focused on partnerships with companies with innovative technology, and Inoflie’s technology could revolutionize the way medical patients with severe conditions are able to meter accurate doses of cannabis in a safe, effective and pain-free way. We anticipate that upon commercialization, Namaste will be able to leverage its relationships to produce pre-filled injectors with medical cannabis. I’m very pleased to be joining Inolife’s board of directors and hope to offer value to their team. We feel strongly that our investment and partnership with Inolife will create strong, long-term value for both companies and their shareholders.”

About Inolife R&D Inc.

Inolife R&D Inc. is an emerging, specialty medical device company focused on developing and commercializing self-administered medical products using novel drug delivery technologies. The company was founded to take advantage of novel techniques of liquid jet and ballistics-based epidermal drug injection. We believe this technology will improve a patient’s quality of life by making medicines more effective and easier to self-administer, and that it will also eliminate the anxiety and inconvenience associated with hypodermic needle injections.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on the Company and its products can be accessed through the links below:

NamasteTechnologies.com
NamasteMD.com
NamasteVapes.ca
Everyonedoesit.ca

FORWARD-LOOKING INFORMATION This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/23/c2011.html

Sean Dollinger, Chief Executive Officer, Direct: +1 (786) 389 9771, Email: [email protected]; Vancouver, BC, V6C 2B5, Main : + 1 (786) 389-9771, namastetechnologies.com, [email protected] CNW Group 2018

Namaste $N.ca Closes Acquisition of Leading #A.I. and Machine-Learning Technology Platform Findify.io for $12,000,000 in Cash and Shares $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:21 AM on Tuesday, May 22nd, 2018

Namaste large new

  • Announced that the Company has closed its previously announced acquisition of Swedish-based A.I. and machine learning technology platform, Findify AB
  • Findify is a global leader in A.I. powered e-commerce technology, delivering solutions such as personalized search, recommendations, and advanced data analytics

VANCOUVER, May 22, 2018 – Namaste Technologies Inc. (“Namaste” or the “Company“) (TSXV: N) (FRA: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company has closed its previously announced acquisition of Swedish-based A.I. and machine learning technology platform, Findify AB (“Findify” or “Findify.io”), through the purchase of all of the issued and outstanding shares of Findify, for a purchase price of US $12,000,000 in a combination of cash and common shares of the Company. Findify is a global leader in A.I. powered e-commerce technology, delivering solutions such as personalized search, recommendations, and advanced data analytics. The acquisition of Findify as a technology platform will bring significant value to Namaste and its shareholders by accelerating the Company’s growth strategy, enhancing conversion rates and revenue and in providing an entry into machine-learning and A.I. for applications for cannabis.

Findify’s Platform and Conversion Rate Optimization

Findify’s platform, which is used by leading e-commerce websites, including Namaste, uses proprietary real-time machine learning algorithms to deliver a truly personalized experience to each and every customer. Through robust data collection, the platform analyzes user behavior and in combination with product trends, it automatically and continuously displays relevant products to each customer at any given time. The ability to deliver accurate and relevant products real-time, leads to increases in revenue, conversion rates and average order value.

Namaste will deploy Findify’s full product suite across its platform in order to bring this intelligence across all consumer touch-points. This focus on conversion rate optimization (CRO) using A.I. and machine learning technology will provide Namaste’s customers and patients, with an enhanced user experience while also increasing sales. The Company’s management team anticipates that the integration of Findify’s full-suite of proprietary technology will increase monetization, deliver a better user experience for customers, and propel revenue growth in both cannabis and hardware sales.

Cannabis A.I.

The Namaste and Findify team are pleased to be bringing the power of artificial intelligence to solve the problem of unpredictability in plant medicine. Findify’s technology will help bring clarity to our consumers and patients, who seek a specific cannabis strain in an ocean of variety, misinformation, uncertainty. Recent studies have revealed that the cannabis plant has 144 cannabinoids and over 100 terpenes, each with beneficial properties in unique combinations, affecting individuals in different ways. In addition to having over a thousand strains and over 200 variations of beneficial compounds, humans have different responses to each of these strains, making it an enormous challenge to find the right strain for the right person and their particular needs. Today, we search for that perfect strain by means of trial & error or guesswork. But Findify’s proprietary machine learning technology will allow us to match each unique individual with the relevant cannabis products for them. The Findify acquisition uniquely positions Namaste to develop a cannabis-focused A.I. platform that will provide a deeper understanding of patients needs and behaviours in an effort to provide a more relevant and personalized experience.

Key terms of the Acquisition:

  • Namaste acquired all issued and outstanding shares of Findify in exchange for:
    • US $2,000,000 in cash, paid upon the closing date of the proposed transaction.
    • US $10,000,000 paid in common shares of Namaste at a mutually agreed price of C$1.80 per common share.

The acquisition of Findify represents a major milestone for Namaste as its largest and first technology-based acquisition. Namaste will roll-out the entire suite of products available through Findify on all touch points in order to bring real-time intelligence across its platform. Findify will also leverage their experience working with 1000+ e-commerce stores, with conversion rate optimization and enhanced UX design.

Management Commentary

Meni Morim, Founder and CEO of Findify comments:

“We are delighted to officially be part of the Namaste Technologies team. We believe that technology can make the world a better place, and we strive to achieve that vision by bringing plant-based holistic medicine to the masses. By leveraging the power of A.I., we can understand complex plant characteristics and match them with patients’ profiles, thus helping patients with ailments such as chronic pain find the right strain of cannabis to alleviate their condition. It’s exciting to be able to use Namaste’s platform to offer people in remote areas access to health professionals and high-quality products.

During the acquisition process, we had the opportunity to work closely with the Namaste management team. It is an incredibly experienced and talented group of people, with drive and dedication which is truly inspiring. We are honored to be part of such a team.

We have spent a significant time reviewing the vision and roadmap of Namaste, and we’re very excited to take part in shaping the future of cannabis. We will be working hard on weaving A.I. into all aspects of the Namaste offering, which will deliver an unparalleled experience to our customers and patients.”

Sean Dollinger, President and CEO of Namaste comments:

“We are very excited to have acquired such an innovative company. Findify’s team have demonstrated themselves to be not only cutting-edge developers but also like-minded in business and strategy. We have already seen the benefits of A.I. and machine-learning in applications of e-commerce and anticipate strong growth in Findify’s existing business, offering this as a service to retailers. Our strategy will be to roll-out the full-suite of Findify’s offering across all Namaste sites with a focus on increasing CRO and in maximizing revenue and profitability. We have devoted ourselves to acquiring and innovating technology for the cannabis industry. We are very excited to have the opportunity to begin testing machine-learning and A.I. applications specifically within the cannabis industry.

In the future, cannabis patients will demand a more personalized online experience, as products and services in the cannabis industry continue to grow exponentially. We remain focused on positioning the company as a global leader in applications of innovative technology within the cannabis industry. We are very proud to have such talented companies and individuals working in partnership with Namaste to enhance a patient’s online buying experience by providing a deeper level personalization that will directly impact the patient’s experience.”

About Findify AB

Findify is a leader in e-commerce machine learning applications, with over 1200 customers in more than 60 countries around the world. Findify has developed a unique machine learning core, that leverages user behaviour, to personalize online experiences in real-time. Findify’s machine learning technology has been proven to deliver up to 27% uplift in conversion rate, and up to 30% uplift in revenue per user.

Findify is an official Shopify Plus Technology Partner, recognized as a “Best-In-Class Solution” for modern, rapidly growing e-Commerce businesses.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Investor Relations

Phone: 561-542-5052 or 250-300-5103

Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward-Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. Neither the TSX Venture Exchange nor its market regulator has reviewed or approved the contents of this press release.

SOURCE Namaste Technologies Inc.

Marijuana Company of America and Global Hemp Group Provide Update on CBD Farm Joint Venture in Scio, Oregon $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 8:38 AM on Tuesday, May 15th, 2018

15233 mcoa

  • Provides an update on their CBD hemp farming project in Scio, Oregon
  • Garden operations are well underway at the farm
  • Initial nursery and propagation rooms for clones have recently been expanded to an additional attached greenhouse
  • Team continues to produce clones for planting in the current season

ESCONDIDO, Calif., May 15, 2018  – MARIJUANA COMPANY OF AMERICA INC. (“MCOA” or the “Company”) (OTC:MCOA) and joint venture partner Global Hemp Group Inc. (CSE:GHG) (OTC:GBHPF) (FRANKFURT:GHG) (the “Partners”) are pleased to provide an update on their CBD hemp farming project in Scio, Oregon (the “Project”).

Garden operations are well underway at the farm. The initial nursery and propagation rooms for clones have recently been expanded to an additional attached greenhouse as the team continues to produce clones for planting in the current season. In order to maximize planting density, an additional 20,000 high yielding CBD hemp clones are being purchased and will be delivered before the end of May to meet the targeted planting schedule of early June.

Five additional greenhouses have now been purchased for the project. The first two 30ft. x 120ft greenhouses are currently being installed and will provide an additional 7,200 sq. ft. of greenhouse space for the project. The three remaining 42ft x 96ft greenhouses will begin installation before the end of May. When installed, these additional greenhouses will increase greenhouse space by a further 12,096 sq. ft., for a total of 19,296 active greenhouse space.

The team will be planting the clones on the first 35 acres at the farm. They will be planted “orchard style”, 4 to 5 feet on center, with rows 5 feet apart to provide space for each plant to receive sufficient sunlight, water and nutrients, and mature to maximum size to produce the highest CBD yield possible upon harvest.

The Scio farm will employ both traditional outdoor orchard style cultivation and perpetual harvest in greenhouses. The Partners are currently evaluating additional greenhouse technologies for expansion of indoor cultivation space to augment its perpetual harvest model square footage. This dual strategy will optimize revenue generation throughout the year to minimize the impact of single crop harvesting in October when most other hemp CBD farms harvest and typically drive prices down. Market prices tend to climb throughout the year as less biomass is available for processing and distribution, as is occurring with current market prices. Starting in August, it is expected that full spectrum CBD oil will be in tight supply and prices will continue to climb until after the October 2018 harvest season is processed.

The team is in the process of ordering the required equipment to facilitate farm operations from planting through harvesting, drying and storage.

In addition, the Partners are currently evaluating a field analytics software application to be employed for data collection and analysis to optimize farming operations. The software will be used to evaluate the three cultivation methods being employed by the Partners in 2018; high yielding CBD cultivars grown orchard style outdoors in Scio, Oregon, perpetual harvest in greenhouses also at Scio, and traditional dense field cropping with lower yielding CBD cultivars in New Brunswick, Canada.  Results will assist the team in determining optimal yield per acre for future expansion of acreage in both the United States and Canada.

“Our evolving project in Scio, Oregon highlights the quality of the team in place as they continue to lean on their many years of experience cultivating hemp.  Activities such as these will help to secure the raw oil that we will need for our hempSMART brand of CBD infused products,” says Donald Steinberg, CEO of Marijuana Company of America.  See our products at www.hempsmart.com

“The Scio, Oregon high yielding CBD hemp project is something that we have been working on putting together most of this year. It’s great to see that the project is now officially underway, and we look forward to sharing pictures and results of the operation as we go forward,” stated Charlie Larsen, President of Global Hemp Group.

About Marijuana Company of America, Inc.
MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™â€, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Global Hemp Group Inc.
Global Hemp Group Inc., is headquartered in Vancouver, BC, Canada, with base operations in Montreal and Los Angeles. The Company is focused on a multi-phased strategy to build a strong presence in the industrial hemp industry in both Canada and the United States. The first phase of this strategy is to develop hemp cultivation with the objective of extracting cannabinoids (CBD, CBG, CBN & CBC) and creating a near term revenue stream that will allow the Company to expand and develop successive phases of the strategy. The second phase of the plan will focus on the development of value-added industrial hemp products utilizing the processing of the whole hemp plant, as envisioned in the Company’s Hemp Agro-Industrial Zone (HAIZ) strategy.

Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.